Scott Shultz has over 20 years of pharmaceutical development experience at Merck in the process and analytical development areas. Since 2008 Scott has led numerous efforts in the materials...
Haitao Zhang is an Associate Research Fellow in Chemical Development with Sumitomo Pharma America since 2012. In the current role, he is responsible for in developing, and demonstrating commercially...
By Cheng Yi Chen, Ph.D. Chemical Processing R&D, Mirati Therapeutics, San Diego, CA 92130, USA chenc@mirati.com A new approach to stereopure atropisomeric molecules is enabled by a continuous flow-crystallization...
By Haitao Zhang, Ph.D. Associate Research Fellow, Sumitomo Pharma America, Inc. The crystallization of active pharmaceutical ingredients, particularly those with multiple polymorphic forms, particle size and morphology critical properties,...
By Fredrik Nordstrom, Ph.D. Material and Analytical Sciences, Boehringer-Ingelheim, Ridgefield, CT, 06877 fredrik.nordstrom@boehringer-ingelheim.com The decision for selecting and optimizing the synthetic route of a drug candidate is to a...
Dr. Fredrik Nordstrom leads a solid state and crystallization group within the Material and Analytical Science department at Boehringer-Ingelheim, Ridgefield, CT. The Solid State Chemistry group is responsible for...
Luca Iuzzolino works as a Senior Scientist in the Computational and Structural Chemistry (CSC) group within Merck & Co., Inc. His work place is in Rahway, NJ. In his...
Dr. Vivian Bi is a Senior Director and Head of Pharmaceutical Development at Aclaris Therapeutics Inc., where she looks after the development of multiple pharmaceutical products from preclinical to...
Veeran Gowda Kadajji, holds a PhD in Pharmaceutical sciences. In his current role, he leads drug product development group at J-STAR Research in Cranbury, NJ. He has close to...
Dr. Qi Gao is a Distinguished Research Fellow of J-Star Research. She received a B.S. degree in Chemical Engineering and Materials Science from Tsinghua University and a Ph.D. in...
